文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

晚期盆腔恶性肿瘤的肿瘤血管外科治疗

Oncovascular surgery for advanced pelvic malignancy.
PubMed 文献 · Br J Surg · 2023-01-01

本文为叙述性综述,总结晚期盆腔肿瘤累及大血管时行整块血管切除与重建的术前评估、技术与结局。手术时间510-678分钟,中位失血2-5升,专科中心R0切除率58-82%,主要并发症30-40%,围术期死亡0-4%,约50%患者可获得长期生存。

要点

  • 晚期盆腔肿瘤侵犯髂血管时,整块切除重建可行,肿瘤学与生存结局与中央盆腔肿瘤相当。
  • 主要并发症风险30-40%,与不涉及血管的扩大盆腔切除相似,围术期死亡0-4%。
  • 髂总或外髂静脉慢性狭窄或闭塞时,可安全结扎不重建,避免血栓和肺栓塞风险。

核心结论

  • 扩大盆腔切除时整块切除髂总或外髂血管对侵犯大血管的晚期肿瘤是可行策略。
  • 肿瘤学、并发症和生存结局与更中央的盆腔肿瘤相当。
  • 髂总或外髂静脉慢性狭窄或闭塞时,结扎不重建可安全施行并避免血栓和肺栓塞风险。

研究设计与样本

  • 叙述性综述,纳入已发表的晚期盆腔肿瘤大血管切除与重建数据,涵盖术前评估、技术和结局。
  • 基于当前文献和作者个人经验提供治疗决策建议,并讨论争议与未来方向。

主要发现

  • 手术时间延长至510-678分钟,中位失血2-5升。
  • 当代专科中心R0切除率为58-82%。
  • 主要并发症风险30-40%,与不涉及血管的扩大盆腔切除相似。
  • 围术期死亡率为0-4%。
  • 约50%患者可获得长期生存。

关键数值与推荐

  • R0切除率58-82%(当代专科中心)。
  • 主要并发症风险30-40%,与不涉及血管的扩大盆腔切除相似。
  • 围术期死亡率0-4%,肢体丢失风险0%。

临床怎么用

  • 对侵犯髂总或外髂血管的晚期盆腔肿瘤,可考虑整块切除重建。
  • 髂总或外髂静脉慢性狭窄或闭塞时,可结扎不重建。
  • 间置移植物的选择仍存争议。

局限性

  • 间置移植物的选择仍存争议。
  • 需要比较术前预防性解剖外重建与术中解剖重建的长期对照数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The number of units with experience in extended radical resections for advanced pelvic tumours has grown substantially in recent years. The use of complex vascular resections and reconstructive techniques in these units is expected to increase with experience. This review aimed to provide a cutting-edge overview of this evolving surgical approach to complex pelvic tumours with vascular involvement. METHODS: This was a narrative review of published data on major vascular resection and reconstruction for advanced pelvic tumours, including preoperative evaluation, techniques used, and outcomes. Advice for treatment decisions is provided, and based on current literature and the personal experience of the authors. Current controversies and future directions are discussed. RESULTS: Major vascular resection and reconstruction during surgery for advanced pelvic tumours is associated with prolonged operating time (510-678 min) and significant blood loss (median 2-5 l). R0 resection can be achieved in 58-82 per cent at contemporary specialist units. The risk of major complications is similar to that of extended pelvic resection without vascular involvement (30-40 per cent) and perioperative mortality is acceptable (0-4 per cent). Long-term survival is achievable in approximately 50 per cent of patients. CONCLUSION: En bloc resection of the common or external iliac vessels during exenterative pelvic surgery is a feasible strategy for patients with advanced tumours which infiltrate major pelvic vascular structures. Oncological, morbidity, and survival outcomes appear comparable to more central pelvic tumours. These encouraging outcomes, combined with an increasing interest in extended pelvic resections globally, will likely lead to more exenteration units developing oncovascular experience. En bloc resection of the common or external iliac vessels during exenterative pelvic surgery is a feasible strategy for patients with advanced tumours. The risk of major complications is similar to that of extended pelvic resection without vascular involvement (30–40 per cent), and the risk of mortality or limb loss is very low in contemporary practice (0–4 per cent and 0 per cent, respectively). Oncological and survival outcomes appear comparable to more central pelvic tumours. The choice of interposition grafts remains contentious. Where the common or external iliac vein is chronically stenosed or occluded, ligation without reconstruction can be safely performed and avoids the risk of thrombosis and pulmonary embolism. Comparative long-term data on pre-emptive extra anatomical reconstruction versus intraoperative anatomical reconstruction is required.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Rajendran S, Brown KGM, Solomon MJ, et al. Oncovascular surgery for advanced pelvic malignancy. Br J Surg. 2023. PMID: 36427187. doi:10.1093/bjs/znac414

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。